recent articles
The Roche VENTANA TROP2 (EPR20043) RxDx Device is an immunohistochemistry (IHC) assay combined with a digital pathology algorithm to determine patient treatment. The device uses artificial intelligence-based image analysis with a...
Aiforia selected to provide AI-assisted diagnostic solutions to regional health authorities in Italy Aiforia Technologies Plc PRESS RELEASE January 24, 2025 at 3.45 p.m. EET The Lombardy region health authorities in Italy have selected...
Biofidelity: Fast, simple, decentralized testing from tissue and blood using standard PCR instruments New data to be presented at AMP 2024 demonstrates best-in-class tissue and blood performance from both DNA and RNA CAMBRIDGE,...
Learn more about Indica Labs and their Lung Macrodissect tool in this informational brochure. The Lung Macrodissect AI tool from Indica Labs quantifies tumor content to facilitate downstream molecular testing in cases of NSCLC, helping labs...
From Diagnostics World: By Deborah Borfitz March 7, 2024 | Biomedical engineers have a significant role to play in the development and optimization of liquid biopsies to further precision oncology. Although molecular...
A new pathologic scoring system that accurately assesses how much lung tumor is left after a patient receives presurgical cancer treatments can be used to predict survival, according to new research led by investigators at the Bloomberg~Kimmel...